Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is China Resources Medical Holdings Co Debt-to-Equity?
China Resources Medical Holdings CoCMHDF 89 Debt-to-Equity is 0.13 as of Dec. 2025, which is at its 10-year median of 0.13. GuruFocus rates CMHDF with a GF Score™ of 89/100 and a GF Value™ of $0.91. The stock has 5 warning signs investors should review. Among 557 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks better than 76.12% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
CMHDF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.13 Max: 0.4
Current: 0.13
During the past 13 years, the highest Debt-to-Equity Ratio of China Resources Medical Holdings Co was 0.40. The lowest was 0.04. And the median was 0.13.
CMHDF's Debt-to-Equity is ranked better than 76.12% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.4
vs CMHDF: 0.13
China Resources Medical Holdings Co (OTCPK:CMHDF) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
China Resources Medical Holdings Co Debt-to-Equity Related Terms
China Resources Medical Holdings Co Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Debt-to-Equity Chart
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co (CMHDF) has a Debt-to-Equity of 0.13 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on China Resources Medical Holdings Co and its competitors. This is near median its historical median of 0.13. Over the past decade, China Resources Medical Holdings Co's Debt-to-Equity has ranged from 0.04 to 0.40. According to the industry distribution chart, China Resources Medical Holdings Co ranks #133 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 23.9%.
Is China Resources Medical Holdings Co's Debt-to-Equity too high?
China Resources Medical Holdings Co's current Debt-to-Equity of 0.13 is near median its 10-year median of 0.13. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.40. The Healthcare Providers & Services industry median Debt-to-Equity is 0.40. China Resources Medical Holdings Co's value of 0.13 is 67.5% below this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #133 out of 557 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Medical Holdings Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #133 out of 557 companies for Debt-to-Equity. This places China Resources Medical Holdings Co in the top 24% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.40. China Resources Medical Holdings Co's value of 0.13 is 67.5% below this benchmark. Historically, China Resources Medical Holdings Co's own Debt-to-Equity has ranged from 0.04 to 0.40 over the past decade. While the company's 10-year median is 0.13 vs. the industry median of 0.40, China Resources Medical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current Debt-to-Equity of 0.13 is 67.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current Debt-to-Equity is 0.13, which is near median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Debt-to-Equity of 0.13. The stock's GF Value™ is $0.91, compared to a current price of $0.58 — trading 36.3% below its estimated fair value. The current Debt-to-Equity is 0.13, which is near median its 10-year median of 0.13 and 67.5% below the Healthcare Providers & Services industry median of 0.40. China Resources Medical Holdings Co's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Debt-to-Equity is 0.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 36.3% below its estimated GF Value™ of $0.91.
Key valuation signals for CMHDF:
Debt-to-Equity: 0.13 (near median its 10-year median of 0.13)
GF Value™: $0.91 vs. price of $0.58 (36.3% below fair value)
Industry Position: 67.5% below the Healthcare Providers & Services median (#133 of 557)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Business Description
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
89GF Score
Get the complete analysis for CMHDF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
